Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells.

International journal of oncology - 1 Sept 2005

Supriatno, Harada Koji, Yoshida Hideo, Sato Mitsunobu

Abstract excerpt

Cyclin-dependent kinase (CDK) inhibitor p27Kip1 is a diagnostic and prognostic marker of various malignancies. Low expression of p27Kip1 reflects poor prognosis, and an inverse correlation between the expression of p27Kip1 and degree of tumor malignancy has been reported. Because p27Kip1 mutation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COP9 Signalosome Complex
Share to Cyclin-Dependent Kinase Inhibitor p27
Share to DNA Fragmentation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Head and Neck Neoplasms

Share to Oligonucleotides, Antisense

Share to Peptide Hydrolases

Share to S-Phase Kinase-Associated Proteins

Share to Xenograft Model Antitumor Assays

Source

Identifiers

PMID: 16077910

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16077910-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells.PMID 16077910Read ↗

Effect of intratumoral injection of mutant type p27Kip1 followed by in vivo electroporation on radiotherapy-resistant human oral tongue cancer xenografts.Semantic proximity Read ↗

Mutant p27(Kip1) and its potential effect as hepatocellular gene therapy.Semantic proximity Read ↗

FOXO3a shRNA and simultaneous induction of P27Kip1gene Inhibit the Breast Cancer Growth in Nude MiceSemantic proximity Read ↗

Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.Semantic proximity Read ↗

Transfection of p27(Kip1) threonine residue 187 mutant type gene, which is not influenced by ubiquitin-mediated degradation, induces cell cycle arrest in oral squamous cell carcinoma cells.Semantic proximity Read ↗

Molecular biology in head and neck cancer.Semantic proximity Read ↗

p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesisSemantic proximity Read ↗

Adenovirus expressing mutant p27kip1 enhanced apoptosis and inhibited the growth of xenografted human breast cancer.Semantic proximity Read ↗

p27kip1: a target for tumor therapies?Semantic proximity Read ↗

Effect of mutant p27(kipl) gene on human cholangiocarcinoma cell line, QBC(939).Semantic proximity Read ↗

Antitumor bioactivity of adenovirus-mediated p27mt in colorectal cancer cell line SW480.Semantic proximity Read ↗

p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.